You are here

  • Home
  • Archive
  • Volume 75, Issue 1
  • MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

Citation Tools

Article menu
Download PDFPDF
Original research
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Brunelli M, Tafuri A, Cima L, et al
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma
Journal of Clinical Pathology 2022;75:39-44.